Results 151 to 160 of about 3,790 (190)

INTRAVENOUS LABETALOL IN HYPERTENSIVE EMERGENCY

Lancet, The, 1979
D L Davies, A M Cumming
exaly   +2 more sources

INTRAVENOUS LABETALOL IN SEVERE HYPERTENSION

Lancet, The, 1975
J J Brown, J I S Robertson, J I Robertson   +2 more
exaly   +2 more sources

Intravenous Labetalol in Acute Aortic Dissection

JAMA: The Journal of the American Medical Association, 1987
To the Editor.— In their CASE REPORT on labetalol hydrochloride therapy for acute aortic dissection, Grubb et al1used a 20-mg bolus followed by a continuous infusion of 2 mg/min for two days. The total intravenous dose was therefore 5.78 g in 48 hours. The manufacturer suggests a maximum dose of 300 mg/d.2Could the authors please comment on the dosing
B P, Grubb, C, Sirio, R, Zelis
  +7 more sources

Pharmacodynamics of intravenous labetalol and follow-up therapy with oral labetalol

Clinical Pharmacology and Therapeutics, 1985
The effectiveness, safety, and pharmacodynamics of repeated doses of intravenous labetalol for rapid reduction of severe hypertension and of subsequent oral labetalol dosing were studied. Twelve patients with severe hypertension were admitted to the hospital after the withholding of antihypertensive therapy for 2 to 14 days.
N D, Vlachakis, R F, Maronde, J W, Maloy, M, Medakovic, N, Kassem   +4 more
openaire   +2 more sources

Treatment of severe hypertension with intravenous labetalol

Clinical Pharmacology and Therapeutics, 1982
The effectiveness of repeated intravenous injections of labetalol in reducing blood pressure (BP) was evaluated in patients with severe hypertension. The subjects were 10 patients who were 29 to 61 yr old and who had diastolic blood pressure (DBP) of 125 mm Hg or higher. Repeated injections titrated from 20 to 80 mg were given at 15-min intervals until
V, Papademetriou, A V, Notargiacomo, I M, Khatri, E D, Freis   +3 more
openaire   +2 more sources

Emergency Treatment of Severe Hypertension with Intravenous Labetalol

Medical Journal of Australia, 1978
The effects of intravenously administered labetalol on blood pressure and pulse rate were examined in 17 patients with severe hypertension. Prompt and sustained falls in supine blood pressure and pulse rate occurred in ten patients (responders), but seven patients showed little or no change in either measurement (non-responders).
B P, McGrath, P G, Matthews, N M, Walter, B W, Maydom, C I, Johnston   +4 more
openaire   +2 more sources

Hemodynamic effects of intravenous labetalol in essential hypertension

Clinical Pharmacology and Therapeutics, 1983
Labetalol inhibits alpha- and beta-adrenergic receptors. Systemic and regional hemodynamic alterations after intravenous labetalol and its cardiovascular reflexive and metabolic effects were evaluated in 12 subjects with mild to moderately severe essential hypertension.
F G, Dunn, W, Oigman, F H, Messerli, G R, Dreslinski, E, Reisin, E D, Frohlich   +5 more
openaire   +2 more sources

Intravenously administered labetalol for treatment of hypertension in children

The Journal of Pediatrics, 1992
Thirteen children (ages 9.2 +/- 3.7 years, mean +/- SD) received intravenous doses of labetalol, an alpha 1- and beta-adrenergic blocker, on 15 separate occasions for treatment of hypertension. In 12 of 15 episodes an initial dose of 0.55 +/- 0.34 mg/kg was given; in all 15 a continuous infusion of 0.78 +/- 0.39 mg/kg per hour was utilized for 67.3 +/-
T E, Bunchman, R E, Lynch, E G, Wood
openaire   +2 more sources

Intravenous Labetalol and Intravenous Diazoxide in Severe Hypertension Complicating Pregnancy

Australian and New Zealand Journal of Obstetrics and Gynaecology, 1986
Summary: The results of a prospective trial to evaluate the use of diazoxide and labetalol given intravenously in the management of severe hypertensive disease in pregnancy are presented.Both drugs had an efficient hypotensive action. The reduction in blood pressure in the labetalol group was better controlled and this may be a factor influencing ...
openaire   +2 more sources

Intravenous Labetalol in the Management of Resistant Hypertensive Emergency

Drug Intelligence & Clinical Pharmacy, 1987
A case of intravenous labetalol in the treatment of a resistant hypertensive emergency is reported. Although there have been several reports of the use of oral labetalol in resistant hypertension, no intravenous administration in hypertensive emergency resistant to other drugs has been reported to date.
openaire   +2 more sources